Brief: Sight Sciences Q3 Revenue USD 20.2 Million Vs. IBES Estimate USD 20.4 Million
07/11/2024 21:05
Nov 07 (Reuters) - Sight Sciences Q3 gross margin 84%. * Q3 net income USD -11.1 million vs. IBES estimate USD -9.74 million * Q3 operating expenses USD 28.1 million * Q3 gross profit USD 16.9 million
Recent news on Sight Sciences
See all newsSight Sciences raises FY 2026 revenue outlook
Brief: Sight Sciences Q1 Revenue USD 19.7 Million Vs. IBES Estimate USD 18.5 Million
Brief: Sight Sciences U.S. District Court Issued Order On Post-Trial Motions In Patent Infringement Case Against Alcon Originally Filed On Sep 16, 2021
Sight Sciences Q4 revenue rises 7%
Brief: Sight Sciences Announces Preliminary, Unaudited Fourth Quarter And Full Year 2025 Financial Highlights